| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.196 | 67.972 | 61.392 | 68.636 | 69.333 | 60.391 | 65.983 | 69.654 | 74.552 | 73.777 |
| Total Income - EUR | 63.526 | 68.525 | 62.255 | 69.697 | 69.495 | 65.559 | 66.154 | 69.654 | 74.552 | 75.577 |
| Total Expenses - EUR | 41.625 | 42.169 | 48.819 | 55.876 | 72.473 | 45.827 | 41.226 | 52.674 | 60.704 | 61.970 |
| Gross Profit/Loss - EUR | 21.901 | 26.355 | 13.436 | 13.820 | -2.978 | 19.732 | 24.927 | 16.981 | 13.849 | 13.607 |
| Net Profit/Loss - EUR | 20.027 | 25.670 | 12.813 | 13.125 | -3.673 | 19.135 | 24.406 | 16.319 | 13.215 | 11.386 |
| Employees | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Balazs Diagnosticum S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31.149 | 39.404 | 33.946 | 27.659 | 26.242 | 52.638 | 48.615 | 59.742 | 41.635 | 25.237 |
| Current Assets | 21.108 | 12.856 | 14.350 | 18.285 | 18.013 | 21.944 | 27.145 | 18.778 | 20.630 | 17.669 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.310 | 9.872 | 0 | 81 | 80 | 2.897 | 7.991 | 1.307 | 1.461 | 302 |
| Cash | 1.797 | 2.984 | 14.350 | 18.204 | 17.933 | 8.297 | 8.471 | 6.755 | 8.485 | 11.336 |
| Shareholders Funds | 41.285 | 50.381 | 37.106 | 36.973 | 32.584 | 51.102 | 74.374 | 51.969 | 57.951 | 39.912 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 10.971 | 1.879 | 11.190 | 8.972 | 11.672 | 23.480 | 1.553 | 26.551 | 4.434 | 3.001 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Balazs Diagnosticum S.r.l.